Merck Announces FDA Orphan Drug Designation for Bifunctional I...
DARMSTADT, Germany, December 10, 2018, /PRNewswire-AsiaNet/-- The information contained is not intended for distribution in the USA, Canada or the UK- FDA grants M7824, an investigational bifunctional immunotherapy, orphan drug designation in biliary tract cancer- First regulatory designat...
Read more https://view-release/?pr-id=76693